Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Clinical trial NCT02389231 · TERMINATED
Trial details
- NCT number
- NCT02389231
- Sponsor
- University Hospital, Bordeaux
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-17
- Primary completion
- 2018-11-16
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.